Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ADDYY Adidas	$98.88 +0.7%	$109.79	$94.33 ▼ $137.73	$35.31B	1.18	65,890 shs	114,020 shs
BAC Bank of America	$50.51 +0.3%	$47.39	$33.06 ▼ $50.64	$374.11B	1.31	41.99 million shs	32.86 million shs
NKE NIKE	$77.98 -0.1%	$73.60	$52.28 ▼ $90.62	$115.17B	1.27	16.46 million shs	7.47 million shs
PFE Pfizer	$24.60 -1.9%	$24.76	$20.92 ▼ $30.43	$139.86B	0.52	45.14 million shs	43.29 million shs
SBUX Starbucks	$88.02 +0.4%	$92.15	$75.50 ▼ $117.46	$100.05B	1.02	10.41 million shs	7.90 million shs

The Next 7 Blockbuster Stocks for Growth Investors

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ADDYY Adidas	+0.29%	-0.83%	-13.75%	-21.48%	-21.37%
BAC Bank of America	+0.40%	+4.26%	+4.55%	+13.94%	+27.11%
NKE NIKE	-0.68%	+2.66%	-1.35%	+27.30%	-8.31%
PFE Pfizer	+0.44%	-1.18%	+3.06%	+6.98%	-13.04%
SBUX Starbucks	+1.19%	-2.07%	-6.42%	+4.30%	-11.10%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
ADDYY Adidas	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
BAC Bank of America	4.8633 of 5 stars	2.4	3.0	4.2	3.3	2.8	2.5	3.1
NKE NIKE	4.4288 of 5 stars	2.3	4.0	4.2	1.5	3.0	2.5	1.3
PFE Pfizer	4.8797 of 5 stars	2.2	3.0	4.2	4.5	3.4	1.7	3.1
SBUX Starbucks	4.6116 of 5 stars	3.3	3.0	3.3	1.9	2.7	1.7	1.9

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ADDYY Adidas	3.00	Buy	N/A	N/A
BAC Bank of America	2.77	Moderate Buy	$50.13	-0.76% Downside
NKE NIKE	2.70	Moderate Buy	$78.22	0.31% Upside
PFE Pfizer	2.39	Hold	$28.12	14.30% Upside
SBUX Starbucks	2.58	Moderate Buy	$104.40	18.61% Upside

Current Analyst Ratings Breakdown

Latest NKE, SBUX, PFE, BAC, and ADDYY Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/26/2025	NKE NIKE	Zacks Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong Sell ➝ Hold
8/22/2025	NKE NIKE	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$115.00
8/18/2025	NKE NIKE	Sanford C. Bernstein Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform ➝ Outperform
8/12/2025	SBUX Starbucks	Loop Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target		$165.00
8/12/2025	SBUX Starbucks	Baird R W Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Hold ➝ Strong-Buy
8/12/2025	SBUX Starbucks	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Neutral ➝ Outperform	$100.00 ➝ $115.00
8/6/2025	PFE Pfizer	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Neutral ➝ Neutral	$25.00 ➝ $26.00
8/6/2025	PFE Pfizer	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Equal Weight ➝ Equal Weight	$32.00 ➝ $33.00
8/6/2025	PFE Pfizer	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Neutral ➝ Neutral	$27.00 ➝ $28.00
7/31/2025	SBUX Starbucks	Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Neutral ➝ Neutral	$79.00 ➝ $90.00
7/30/2025	BAC Bank of America	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Outperform ➝ Outperform	$55.00 ➝ $57.00

(Data available from 8/28/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ADDYY Adidas	$25.63B	1.38	$6.01 per share	16.45	$17.78 per share	5.56
BAC Bank of America	$104.52B	3.58	$3.87 per share	13.05	$37.28 per share	1.35
NKE NIKE	$46.31B	2.49	$2.70 per share	28.83	$8.95 per share	8.71
PFE Pfizer	$63.63B	2.20	$4.31 per share	5.71	$15.66 per share	1.57
SBUX Starbucks	$36.18B	2.77	$4.80 per share	18.34	($6.76) per share	-13.02

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ADDYY Adidas	$826.72M	$3.67	26.94	24.29	0.54	4.93%	20.68%	5.99%	11/4/2025 (Estimated)
BAC Bank of America	$27.13B	$3.42	14.77	11.58	1.95	14.81%	10.25%	0.84%	10/15/2025 (Estimated)
NKE NIKE	$3.22B	$2.16	36.10	33.33	2.86	6.95%	23.33%	8.57%	10/7/2025 (Estimated)
PFE Pfizer	$8.03B	$1.88	13.09	8.12	0.89	16.84%	21.42%	9.12%	11/4/2025 (Estimated)
SBUX Starbucks	$3.76B	$2.32	37.94	24.05	5.14	7.18%	-36.23%	8.51%	10/29/2025 (Estimated)

Latest NKE, SBUX, PFE, BAC, and ADDYY Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/5/2025	Q2 2025	PFE Pfizer	$0.58	$0.78	+$0.20	$0.51	$13.43 billion	$14.65 billion
7/30/2025	Q2 2025	ADDYY Adidas	$1.13	$1.15	+$0.02	$1.17	$6.30 billion	$6.86 billion
7/29/2025	Q3 2025	SBUX Starbucks	$0.64	$0.50	-$0.14	$0.48	$9.29 billion	$9.46 billion
7/16/2025	Q2 2025	BAC Bank of America	$0.86	$0.89	+$0.03	$0.89	$26.79 billion	($22,273.00) million
6/26/2025	Q4 2025	NKE NIKE	$0.12	$0.14	+$0.02	$0.14	$10.69 billion	$11.10 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
ADDYY Adidas	$0.76	0.77%	N/A	20.71%	N/A
BAC Bank of America	$1.12	2.22%	N/A	32.75%	11 Years
NKE NIKE	$1.60	2.05%	N/A	74.07%	22 Years
PFE Pfizer	$1.72	6.99%	N/A	91.49%	16 Years
SBUX Starbucks	$2.44	2.77%	N/A	105.17%	15 Years

Latest NKE, SBUX, PFE, BAC, and ADDYY Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
8/7/2025	NKE NIKE	quarterly	$0.40	2.15%	9/2/2025	9/2/2025	10/1/2025
7/23/2025	BAC Bank of America	quarterly	$0.28	2.33%	9/5/2025	9/5/2025	9/26/2025
6/25/2025	PFE Pfizer	quarterly	$0.43	7.08%	7/25/2025	7/25/2025	9/2/2025
6/24/2025	SBUX Starbucks	quarterly	$0.61	2.64%	8/15/2025	8/15/2025	8/29/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ADDYY Adidas	0.31	1.29	0.72
BAC Bank of America	1.14	0.80	0.79
NKE NIKE	0.60	2.21	1.50
PFE Pfizer	0.65	1.16	0.85
SBUX Starbucks	N/A	0.76	0.55

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
ADDYY Adidas	N/A
BAC Bank of America	70.71%
NKE NIKE	64.25%
PFE Pfizer	68.36%
SBUX Starbucks	72.29%

Insider Ownership

Company	Insider Ownership
ADDYY Adidas	N/A
BAC Bank of America	0.30%
NKE NIKE	0.80%
PFE Pfizer	0.06%
SBUX Starbucks	0.09%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
ADDYY Adidas	62,035	357.10 million	N/A	Not Optionable
BAC Bank of America	217,000	7.41 billion	7.38 billion	Optionable
NKE NIKE	79,100	1.48 billion	1.47 billion	Optionable
PFE Pfizer	83,000	5.69 billion	5.68 billion	Optionable
SBUX Starbucks	402,000	1.14 billion	1.14 billion	Optionable

NKE, SBUX, PFE, BAC, and ADDYY Headlines

Recent News About These Companies

“…Necessary Impairment Provision” Starbucks Stock (NASDAQ:SBUX) Notches Up Despite Malaysian Hit

4 hours ago | tipranks.com

Starbucks Eyes China Partnership: Can It Unlock the Next Growth Cycle?

August 28 at 11:56 AM | zacks.com

Starbucks Corporation $SBUX Shares Sold by Zuckerman Investment Group LLC

August 28 at 9:29 AM | marketbeat.com

Epoch Investment Partners Inc. Decreases Stake in Starbucks Corporation $SBUX

August 28 at 8:09 AM | marketbeat.com

Ceredex Value Advisors LLC Raises Holdings in Starbucks Corporation $SBUX

August 28 at 7:54 AM | marketbeat.com

FORA Capital LLC Takes Position in Starbucks Corporation $SBUX

August 28 at 7:54 AM | marketbeat.com

Starbucks Corporation $SBUX Shares Acquired by Caisse DE Depot ET Placement DU Quebec

August 28 at 7:18 AM | marketbeat.com

3 Must-Know Facts About Starbucks Before You Buy the Stock

August 28 at 6:50 AM | fool.com

Starbucks Corporation $SBUX Shares Sold by Northwestern Mutual Wealth Management Co.

August 28 at 5:51 AM | marketbeat.com

What to know about Cracker Barrel's logo misfire and what could happen next

...

August 27 at 3:45 PM | marketbeat.com

Starbucks vs. Dutch Bros: Which Coffee Stock is a Better Buy Now?

August 27 at 11:26 AM | zacks.com

WCG Wealth Advisors LLC Sells 2,864 Shares of Starbucks Corporation $SBUX

August 27 at 9:05 AM | marketbeat.com

Starbucks Corporation $SBUX Shares Sold by Corebridge Financial Inc.

August 27 at 8:38 AM | marketbeat.com

Soros Capital Management LLC Buys 19,430 Shares of Starbucks Corporation $SBUX

August 27 at 8:04 AM | marketbeat.com

Comerica Bank Decreases Stock Position in Starbucks Corporation $SBUX

August 27 at 7:32 AM | marketbeat.com

Pumpkin-Spice Season Returns: Starbucks, Rival Coffee Chains Hope For Sales Boost From Refreshed Menus Amid Weak Market

August 27 at 5:32 AM | msn.com

Starbucks’ Fall Menu Looks Attractive. So Does the Competition.

August 27 at 4:31 AM | barrons.com

Autumn in August: Starbucks brings Pumpkin Spice Latte back to its menu

August 26 at 7:26 PM | msn.com

Far From Piping Hot,” Starbucks Stock (NASDAQ:SBUX) Notches Up Amid Growing Concerns

August 26 at 7:26 PM | msn.com

Starbucks' (NASDAQ:SBUX one-year decrease in earnings delivers investors with a 8.0% loss

August 26 at 7:26 PM | finance.yahoo.com

This Spread Strategy Can Turn A Profit From Stalling Starbucks Stock

August 26 at 1:51 PM | investors.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

NKE, SBUX, PFE, BAC, and ADDYY Company Descriptions

Adidas OTCMKTS:ADDYY

$98.88 +0.69 (+0.70%)

As of 03:59 PM Eastern

adidas AG, together with its subsidiaries, designs, develops, produces, and markets athletic and sports lifestyle products in Europe, the Middle East, Africa, North America, Greater China, the Asia-Pacific, and Latin America. It offers footwear, apparel, and accessories and gear, such as bags and balls under the adidas brand; golf footwear and apparel under the adidas Golf brand; and outdoor footwear under the Five Ten brand. It sells its products through its own retail stores; mono-branded franchise stores and shop-in-shops; and wholesale and its e-commerce channels. The company was formerly known as adidas-Salomon AG and changed its name to adidas AG in June 2006. adidas AG was founded in 1920 and is headquartered in Herzogenaurach, Germany.

Bank of America NYSE:BAC

$50.51 +0.13 (+0.25%)

Closing price 03:59 PM Eastern

Extended Trading

$50.48 -0.03 (-0.07%)

As of 05:06 PM Eastern

Bank of America Corporation, through its subsidiaries, provides banking and financial products and services for individual consumers, small and middle-market businesses, institutional investors, large corporations, and governments worldwide. It operates in four segments: Consumer Banking, Global Wealth & Investment Management (GWIM), Global Banking, and Global Markets. The Consumer Banking segment offers traditional and money market savings accounts, certificates of deposit and IRAs, non-interest and interest-bearing checking accounts, and investment accounts and products; credit and debit cards; residential mortgages, and home equity loans; and direct and indirect loans, such as automotive, recreational vehicle, and consumer personal loans. The GWIM segment provides investment management, brokerage, banking, and trust and retirement products and services; wealth management solutions; and customized solutions, including specialty asset management services. The Global Banking segment offers lending products and services, including commercial loans, leases, commitment facilities, trade finance, and commercial real estate and asset-based lending; treasury solutions, such as treasury management, foreign exchange, short-term investing options, and merchant services; working capital management solutions; debt and equity underwriting and distribution, and merger-related and other advisory services; and fixed-income and equity research, and certain market-based services. The Global Markets segment provides market-making, financing, securities clearing, settlement, and custody services; securities and derivative products; and risk management products using interest rate, equity, credit, currency and commodity derivatives, foreign exchange, fixed-income, and mortgage-related products. Bank of America Corporation was founded in 1784 and is based in Charlotte, North Carolina.

NIKE NYSE:NKE

$77.98 -0.08 (-0.10%)

Closing price 03:59 PM Eastern

Extended Trading

$77.86 -0.12 (-0.15%)

As of 05:06 PM Eastern

NIKE, Inc., together with its subsidiaries, designs, develops, markets, and sells athletic footwear, apparel, equipment, accessories, and services worldwide. The company provides athletic and casual footwear, apparel, and accessories under the Jumpman trademark; and casual sneakers, apparel, and accessories under the Converse, Chuck Taylor, All Star, One Star, Star Chevron, and Jack Purcell trademarks. It also sells a line of performance equipment and accessories comprising bags, sport balls, socks, eyewear, timepieces, digital devices, bats, gloves, protective equipment, and other equipment for sports activities under the NIKE brand; and various plastic products to other manufacturers. In addition, the company markets apparel with licensed college and professional team, and league logos, as well as sells sports apparel; and licenses unaffiliated parties to manufacture and sell apparel, digital devices, and applications and other equipment for sports activities under NIKE-owned trademarks. It sells its products to footwear stores; sporting goods stores; athletic specialty stores; department stores; skate, tennis, and golf shops; and other retail accounts through NIKE-owned retail stores, digital platforms, independent distributors, licensees, and sales representatives. NIKE, Inc. was founded in 1964 and is headquartered in Beaverton, Oregon.

Pfizer NYSE:PFE

$24.60 -0.47 (-1.87%)

Closing price 03:59 PM Eastern

Extended Trading

$24.62 +0.02 (+0.10%)

As of 05:06 PM Eastern

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Starbucks NASDAQ:SBUX

$88.02 +0.36 (+0.41%)

Closing price 04:00 PM Eastern

Extended Trading

$88.04 +0.02 (+0.02%)

As of 05:07 PM Eastern

Starbucks Corporation, together with its subsidiaries, operates as a roaster, marketer, and retailer of coffee worldwide. The company operates through three segments: North America, International, and Channel Development. Its stores offer coffee and tea beverages, roasted whole beans and ground coffees, single serve products, and ready-to-drink beverages; and various food products, such as pastries, breakfast sandwiches, and lunch items. The company also licenses its trademarks through licensed stores, and grocery and foodservice accounts. The company offers its products under the Starbucks Coffee, Teavana, Seattle's Best Coffee, Ethos, Starbucks Reserve, and Princi brands. Starbucks Corporation was founded in 1971 and is based in Seattle, Washington.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare MarketRank™

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest NKE, SBUX, PFE, BAC, and ADDYY Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest NKE, SBUX, PFE, BAC, and ADDYY Earnings

Compare Dividends

Latest NKE, SBUX, PFE, BAC, and ADDYY Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

NKE, SBUX, PFE, BAC, and ADDYY Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

NKE, SBUX, PFE, BAC, and ADDYY Company Descriptions

Adidas OTCMKTS:ADDYY

Bank of America NYSE:BAC

NIKE NYSE:NKE

Pfizer NYSE:PFE

Starbucks NASDAQ:SBUX

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools